This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Delta 9 Cannabis Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Delta 9 Cannabis.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi	48.8%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Recent updates

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

Jun 21

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

May 10

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Mar 26

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

Mar 26

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

Sep 09

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Jul 28

John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares

Dec 24

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Delta 9 Cannabis yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

TSX:DN - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CAD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
3/31/2024	71	-20	4	4	N/A
12/31/2023	71	-18	4	4	N/A
9/30/2023	71	-22	4	5	N/A
6/30/2023	68	-24	3	4	N/A
3/31/2023	68	-26	-3	-1	N/A
12/31/2022	63	-27	-6	-4	N/A
9/30/2022	63	-21	-7	-5	N/A
6/30/2022	62	-14	-8	-6	N/A
3/31/2022	62	-11	-4	-1	N/A
12/31/2021	62	-11	-3	-1	N/A
9/30/2021	59	-8	-6	-2	N/A
6/30/2021	57	-12	-6	-3	N/A
3/31/2021	54	-13	-7	-2	N/A
12/31/2020	52	-6	-4	2	N/A
9/30/2020	48	-8	-6	0	N/A
6/30/2020	42	-4	-10	1	N/A
3/31/2020	38	-3	-16	-3	N/A
12/31/2019	32	11	-26	-12	N/A
9/30/2019	26	12	-34	-10	N/A
6/30/2019	21	11	-35	-14	N/A
3/31/2019	13	10	-35	-15	N/A
12/31/2018	8	-8	-26	-9	N/A
9/30/2018	3	-12	-16	-11	N/A
6/30/2018	2	-11	-10	-7	N/A
3/31/2018	1	-9	-7	-5	N/A
12/31/2017	1	-8	N/A	-5	N/A
9/30/2017	1	-2	N/A	-3	N/A
6/30/2017	1	-2	N/A	-2	N/A
3/31/2017	1	-1	N/A	-1	N/A
12/31/2016	0	-1	N/A	-1	N/A
12/31/2015	1	-1	N/A	-1	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if DN's forecast earnings growth is above the savings rate (2.2%).

Kazançlar ve Piyasa: Insufficient data to determine if DN's earnings are forecast to grow faster than the Canadian market

Yüksek Büyüme Kazançları: Insufficient data to determine if DN's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if DN's revenue is forecast to grow faster than the Canadian market.

Yüksek Büyüme Geliri: Insufficient data to determine if DN's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if DN's Return on Equity is forecast to be high in 3 years time

This company listing is no longer active

Delta 9 Cannabis Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target decreased to CA$0.80

Delta 9 Cannabis Inc. Provides Earnings Guidance for the Quarter and Nine Months Ended September 30, 2022

Price target decreased to CA$0.80

Price target decreased to CA$0.95

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three Months Period Ended March 31, 2022

Delta 9 Cannabis Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Year Ending December 31, 2021

Recent updates

FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN).

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

Delta 9 Cannabis Inc., Annual General Meeting, Jun 28, 2024

Co-Founder exercised options to buy CA$31k worth of stock.

Full year 2023 earnings released: CA$0.10 loss per share (vs CA$0.22 loss in FY 2022)

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

New major risk - Shareholder dilution

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.06 loss in 3Q 2022)

Delta 9 Cannabis Inc. to Report Q3, 2023 Results on Nov 14, 2023

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

New major risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.04 loss in 2Q 2022)

New major risk - Share price stability

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Delta 9 Cannabis Inc. to Report Q2, 2023 Results on Aug 14, 2023

Co-Founder recently sold CA$99k worth of stock

First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.037 loss in 1Q 2022)

Delta 9 Cannabis Inc. to Report Q1, 2023 Results on May 15, 2023

Delta 9 Cannabis Inc. to Report Q4, 2022 Results on Mar 31, 2023

Co-Founder recently sold CA$52k worth of stock

Delta 9 Cannabis Inc. Announces Changes to Board of Directors

Third quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.011 loss in 3Q 2021)

Price target decreased to CA$0.80

Insufficient new directors

Delta 9 Cannabis Inc. Provides Earnings Guidance for the Quarter and Nine Months Ended September 30, 2022

Delta 9 Cannabis Inc. to Report Q3, 2022 Results on Nov 14, 2022

Delta 9 Cannabis Inc. (TSX:DN) acquired All or Substantially All Assets from 10552763 Canada Corp.

Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?

Price target decreased to CA$0.80

Second quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.014 loss in 2Q 2021)

Delta 9 Cannabis Inc. (TSX:DN) entered into an asset purchase agreement to acquire all or Substantially all assets of 10552763 Canada Corp. for CAD 3.25 million.

Joanne Duhoux-Defehr Resigns from Board of Directors of Delta 9 Cannabis Inc

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Price target decreased to CA$0.95

First quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.042 loss in 1Q 2021)

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three Months Period Ended March 31, 2022

Delta 9 Cannabis Inc., Annual General Meeting, Jun 29, 2022

Insufficient new directors

Full year 2021 earnings released: CA$0.11 loss per share (vs CA$0.072 loss in FY 2020)

Delta 9 Cannabis Inc. announced that it has received CAD 9.6 million in funding from Sundial Growers Inc.

Delta 9 Cannabis Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Year Ending December 31, 2021

Is Delta 9 Cannabis (TSE:DN) A Risky Investment?

Insufficient new directors

Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.07 loss in 3Q 2020)

Independent Director recently sold CA$126k worth of stock

Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt

Price target increased to CA$1.13

Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 2Q 2020)

Delta 9 Cannabis Inc. Announces Health Canada Approval for Perimeter Expansion and Vault Area

Price target decreased to CA$1.04

Co-Founder exercised options to buy CA$63k worth of stock.

Co-Founder recently bought CA$53k worth of stock

Co-Founder recently bought CA$53k worth of stock

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three-Month and Six-Month Period Ending June 30, 2021

Co-Founder recently sold CA$138k worth of stock

Consensus revenue estimates fall to CA$66.3m

Co-Founder recently sold CA$115k worth of stock

First quarter 2021 earnings released: EPS CA$0.04 (vs CA$0.023 in 1Q 2020)

Delta 9 Cannabis Inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2021

Delta 9 Cannabis (TSE:DN) Is Carrying A Fair Bit Of Debt

Full year 2020 earnings released: CA$0.07 loss per share (vs CA$0.16 profit in FY 2019)

Delta 9 Cannabis Inc. Provides Update on Strategic Cooperation Agreement with F1NE Cannabis Cultivation LTD

Delta 9 Cannabis Inc. Launches Province Wide Delivery in Saskatchewan and Reserve Online in Alberta

Delta 9 Cannabis Inc. to Report Q4, 2020 Results on Mar 30, 2021